James Shaw

Assistant Professor

University of Manitoba

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

James Shaw is an Assistant Professor at the University of Manitoba, Canada. His research focuses on kidney transplantation, specifically in areas such as donor pool expansion, viral monitoring strategies post-transplant, and the immunological aspects affecting allograft survival. Recent publications highlight his work on BK virus viremia, Epstein-Barr virus chronic load, and the cost-effectiveness of antibody surveillance in transplant patients.

Articles (7)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2020

Collaborators (4)

Ian Gibson

Associate Professor

University of Manitoba

CANADA

View details

Aviva Goldberg

CANADA

View details

Peter Nickerson

Vice Dean Research

University of Manitoba

CANADA

View details

Julie Ho

Professor

University of Manitoba

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Shaw

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Safety and efficacy of a reduced frequency viral monitoring strategy for Epstein‐Barr virus, cytomegalovirus, and BK polyomavirus post‐kidney transplant: A quality assurance initiative

Program Report: Expanding the Deceased Donor Pool in Manitoba With an Age-Targeted Kidney Transplant Program.

Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients.

Epidemiology of Epstein-Barr Virus Chronic High Viral Load in Kidney Transplant Recipients.

A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression

The negative impact of T cell–mediated rejection on renal allograft survival in the modern era

Evidence for the alloimmune basis and prognostic significance of Borderline T cell–mediated rejection

Collaborators (4)

Ian Gibson

Aviva Goldberg

Peter Nickerson

Julie Ho

Make your next move.